Global Infusion Pump Market Size study & Forecast, by Type, Application, End User and Regional Forecasts 2025-2035

Description

The Global Infusion Pump Market, valued at approximately USD 11.94 billion in 2024, is poised to register a compound annual growth rate of about 7.40% between 2025 and 2035, reaching an estimated USD 26.18 billion by the end of the forecast period. Infusion pumps-essential medical devices designed to deliver fluids, nutrients, or medications into a patient's body in controlled amounts-are becoming indispensable in modern healthcare systems. Their precision, programmability, and adaptability to diverse therapeutic applications have made them critical in acute care settings, chronic disease management, and home healthcare. Market expansion is largely underpinned by the rising global prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, along with the growing geriatric population that demands prolonged and complex treatment regimens. Furthermore, advancements in pump technology, including integration with electronic medical records, wireless connectivity, and smart alert systems, are enabling healthcare providers to improve patient safety while reducing human error in medication administration.

A growing emphasis on outpatient care and home-based treatment solutions is further propelling demand for compact, portable, and patient-friendly infusion pump models. This shift aligns with the broader healthcare trend toward cost containment, reduced hospital stays, and improved quality of life for patients managing long-term illnesses. Technological innovations-such as closed-loop systems for insulin delivery, sensor-assisted oncology pumps, and automated drug libraries-are reshaping market dynamics by offering more personalized and adaptive therapies. Additionally, the surge in demand for infusion therapy in oncology, pain management, and critical care, coupled with rapid product approvals and regulatory clearances, has accelerated the pace of adoption worldwide. However, concerns around device malfunctions, cybersecurity threats to connected devices, and the high costs of advanced pump systems remain notable hurdles for widespread implementation in emerging economies.

Regionally, North America accounted for the largest revenue share in 2024, benefiting from advanced healthcare infrastructure, high adoption rates of cutting-edge medical devices, and a well-established reimbursement framework. The U.S., in particular, remains a lucrative market due to its strong focus on integrating smart infusion systems within hospital networks and home healthcare programs. Europe follows closely, driven by robust government support for healthcare modernization, an expanding elderly population, and increasing investments in automated drug delivery systems. Asia Pacific is projected to witness the fastest growth through 2035, spurred by surging healthcare expenditure, rapid hospital infrastructure development, and rising incidences of lifestyle-related diseases in densely populated nations such as China and India. Moreover, government-led initiatives to improve access to essential medical devices, coupled with the expansion of private healthcare providers, are creating fertile grounds for infusion pump adoption in the region.

Major market player included in this report are:

Baxter International Inc.
B. Braun Melsungen AG
ICU Medical, Inc.
Fresenius Kabi AG
Terumo Corporation
Smiths Medical (ICU Medical)
Medtronic plc
Moog Inc.
BD (Becton, Dickinson and Company)
Nipro Corporation
JMS Co., Ltd.
Roche Diagnostics
Zyno Medical
Mindray Medical International Limited
AngioDynamics Inc.

Global Infusion Pump Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Type:

Volumetric Pumps
Syringe Pumps
Enteral Pumps
Insulin Pumps
Elastomeric Pumps
Implantable Pumps
PCA Pumps

By Application:

Diabetes
Oncology
Pain Management
Others

By End User:

Hospitals & Clinics
Ambulatory Care Settings
Home Care Settings
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Infusion Pump Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study (Historical Data - 2023, 2024; Base Year for Estimation - 2024; Forecast period - 2025-2035)

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global Infusion Pump Market Forces Analysis

3.1. Market Forces Shaping The Global Infusion Pump Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising prevalence of chronic diseases (diabetes, cancer) driving sustained demand for infusion therapy
- 3.2.2. Shift toward home healthcare and ambulatory care promoting portable and patient-centric pump adoption
- 3.2.3. Technological advancements - smart pumps, EMR integration, closed-loop insulin systems - enhancing safety and uptake
- 3.2.4. Growing geriatric population and increased surgical volumes necessitating advanced infusion solutions
3.3. Restraints
- 3.3.1. High cost of advanced infusion pump systems and total cost of ownership limiting penetration in emerging markets
- 3.3.2. Cybersecurity vulnerabilities and device malfunction concerns prompting regulatory scrutiny and slowed adoption
- 3.3.3. Reimbursement constraints and fragmented procurement policies across regions affecting purchasing cycles
3.4. Opportunities
- 3.4.1. Expansion of home-care infusion and remote monitoring solutions creating new revenue streams
- 3.4.2. Development of interoperable, cloud-enabled infusion ecosystems and value-added services (maintenance, training)
- 3.4.3. Emerging market growth (Asia Pacific, Latin America) driven by hospital expansion and rising healthcare spend
- 3.4.4. Innovations in miniaturized, implantable and wearable pumps for chronic therapies and targeted drug delivery

Chapter 4. Global Infusion Pump Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Infusion Pump Market Size & Forecasts by Type 2025-2035

5.1. Market Overview
5.2. Global Infusion Pump Market Performance - Potential Analysis (2025)
5.3. Volumetric Pumps
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Syringe Pumps
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Enteral Pumps
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
5.6. Insulin Pumps
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035
5.7. Elastomeric Pumps
- 5.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.7.2. Market size analysis, by region, 2025-2035
5.8. Implantable Pumps
- 5.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.8.2. Market size analysis, by region, 2025-2035
5.9. PCA Pumps
- 5.9.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.9.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Infusion Pump Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Global Infusion Pump Market Performance - Potential Analysis (2025)
6.3. Diabetes
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Oncology
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Pain Management
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
6.6. Others
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.6.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Infusion Pump Market Size & Forecasts by Region 2025-2035

7.1. Infusion Pump Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Infusion Pump Market
- 7.3.1. U.S. Infusion Pump Market
  - 7.3.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.3.1.2. Application breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Infusion Pump Market
  - 7.3.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.3.2.2. Application breakdown size & forecasts, 2025-2035
7.4. Europe Infusion Pump Market
- 7.4.1. UK Infusion Pump Market
  - 7.4.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.1.2. Application breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Infusion Pump Market
  - 7.4.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.2.2. Application breakdown size & forecasts, 2025-2035
- 7.4.3. France Infusion Pump Market
  - 7.4.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.3.2. Application breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Infusion Pump Market
  - 7.4.4.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.4.2. Application breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Infusion Pump Market
  - 7.4.5.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.5.2. Application breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Infusion Pump Market
  - 7.4.6.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.6.2. Application breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Infusion Pump Market
- 7.5.1. China Infusion Pump Market
  - 7.5.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.1.2. Application breakdown size & forecasts, 2025-2035
- 7.5.2. India Infusion Pump Market
  - 7.5.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.2.2. Application breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Infusion Pump Market
  - 7.5.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.3.2. Application breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Infusion Pump Market
  - 7.5.4.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.4.2. Application breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Infusion Pump Market
  - 7.5.5.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.5.2. Application breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Infusion Pump Market
  - 7.5.6.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.6.2. Application breakdown size & forecasts, 2025-2035
7.6. Latin America Infusion Pump Market
- 7.6.1. Brazil Infusion Pump Market
  - 7.6.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.6.1.2. Application breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Infusion Pump Market
  - 7.6.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.6.2.2. Application breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Infusion Pump Market
- 7.7.1. UAE Infusion Pump Market
  - 7.7.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.1.2. Application breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Infusion Pump Market
  - 7.7.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.2.2. Application breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Infusion Pump Market
  - 7.7.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.3.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Baxter International Inc.
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. B. Braun Melsungen AG
8.4. ICU Medical, Inc.
8.5. Fresenius Kabi AG
8.6. Terumo Corporation
8.7. Smiths Medical (ICU Medical)
8.8. Medtronic plc
8.9. Moog Inc.
8.10. BD (Becton, Dickinson and Company)
8.11. Nipro Corporation
8.12. JMS Co., Ltd.
8.13. Roche Diagnostics
8.14. Zyno Medical
8.15. Mindray Medical International Limited
8.16. AngioDynamics Inc.